Feature | March 29, 2012

Telemedicine Improves Hypertension Medication Management

Continuous patient reporting via Internet may promote better blood pressure control

March 29, 2012 — Internet-based telemedicine systems appear to lead to more appropriate and effective pharmacotherapy, better blood pressure control and an overall reduction in cardiovascular risk compared to conventional, periodic office visits, according to research presented this week at the American College of Cardiology (ACC) Annual Scientific Session in Chicago.

Patients who reported blood pressure readings more frequently via a Web-based portal received more timely treatment decisions and medication adjustments from their healthcare team compared to a control group of hypertensive patients who had routine office visits. These findings have important implications for clinical practice given that – aside from lifestyle changes – antihypertensive medications are the most effective way to help patients lower their blood pressure. As many as 65 million American adults have high blood pressure, and roughly 74 percent take medication for it, according to the Centers for Disease Control and Prevention.

“The ongoing monitoring and reporting of blood pressure levels seems to bring about important changes in physician prescribing habits, which we think ultimately benefits patients,” said Val Rakita, M.D., internal medicine resident at Temple University Hospital and the study’s co-investigator. “Based on our findings, physicians appear to prescribe more blood pressure medications for those patients who continue to have high blood pressure despite the medications they are on. In fact, in one subset of patients, not only did we find they were prescribed more blood pressure medications, it also actually led to a larger blood pressure reduction compared to all other groups.”

In this study, patients from two large medical centers were recruited and randomized to receive either usual care or telemedicine with usual care. Patients in the telemedicine group received counseling on cardiovascular disease risk reduction and were given a home blood pressure cuff and trained on how to use it. They were asked to report their blood pressure, heart rate, weight, steps taken per day and tobacco use twice weekly for six months. By the end of the six-month intervention, medications prescribed to those in the control group were virtually unchanged, while there was a small, but significant, increase in the number of medications ordered (2.2 ± 1.2 to 2.34 ± 1.15, p=0.004) for patients in the telemedicine group.

Rakita says that prescribing more medication in the telemedicine group did not signify over-treatment, but was a reflection of more timely decisions to increase and/or adjust medications based on patient self-monitoring and reporting.

Unlike other types of telemedicine, which may include telephone interactions, this study looked at an Internet-based system that supported ongoing communication between patients and healthcare providers.

“This allows for greater convenience for both sides and most likely led to the better results,” Rakita said. “High blood pressure is one of the most important risk factors for cardiovascular disease, which is the number one cause of death in America. Employing an Internet-based patient-physician communication system that can help lower blood pressure could make it possible to reduce patients’ cardiovascular risk.”

This was a secondary analysis of a telemedicine trial of 241 patients with uncontrolled hypertension (BP?150/90 mmHg). More than half of study participants (56.8 percent) were taking one or two blood pressure-lowering medications at the start of the study. The initial average blood pressure was 156/89±14/11 among all patients. All patients had baseline and six-month follow-up visits. Monthly reports on blood pressure and treatment guidelines were provided to both the patient and physician in the telemedicine group.

Although there was no significant difference in the decrease in blood pressure between the two groups overall, the primary group of nondiabetic patients using telemedicine was found to have lower blood pressure compared to all other groups. Rakita said it is reasonable to believe that the use of additional blood pressure medications in the telemedicine group would have translated to an associated drop in blood pressure in these patients had they been followed for a longer period of time.

“The goal of telemedicine is to reduce disease and the burden on the healthcare system in a cost-effective way,” he said. “By showing that a relatively low-cost, Internet-based telemedicine system can change physicians’ prescribing habits and perhaps [lower] blood pressures, this can lead to obvious benefits to patients and the healthcare system.”

This study was funded by the Agency for Healthcare Research and Quality.

For more information: www.ACC.org

Related Content

INRatio, Alere, Abbott, I and R testing, INR testing
Feature | Point of Care Testing| December 07, 2016
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substanti
PET, F-18 florbetaben, cardiac amyloidosis, Princess Alexandria Hospital

In a pilot study, F-18-florbetaben PET imaging appeared promising for differentiating between cardiac amyloidosis and hypertensive heart disease. Image courtesy of W. Phillip Law/Princess Alexandra Hospital, Brisbane, Australia.

News | Nuclear Imaging| December 06, 2016
Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac amyloidosis (abnormal...
coronary CT angiography, CCTA, alcohol consumption, CAD, coronary artery disease, RSNA 2016
News | CT Angiography (CTA)| November 29, 2016
Researchers using coronary computed tomography angiography (CCTA) found no association between light to moderate...
News | Cath Lab| November 21, 2016
November 21, 2016 – A single-center study sponsored by the National Institutes of Health (NHLBI) failed to show an ea
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid| November 18, 2016
November 18, 2016 — InspireMD Inc.
Boston Scientific, HeartLogic Heart Failure Diagnostic Service, MultiSENSE trial data, AHA Scientific Sessions 2016
News | Heart Failure| November 18, 2016
Boston Scientific recently announced results from the first clinical trial evaluating the performance of the HeartLogic...
cardiac rehabilitation, depression, death risk, heart surgery, Intermountain Medical Center Heart Institute, AHA Scientific Sessions 2016
News | Cardiac Rehabilitation| November 15, 2016
Depression has been known to be associated with poor cardiovascular outcomes. But if patients who are depressed attend...
atrial fibrillation, warfarin, dementia, Intermountain Medical Center Heart Institute, American Heart Association, AHA Scientific Sessions 2016
News | Atrial Fibrillation| November 15, 2016
Atrial fibrillation patients who use warfarin to lower risk of stroke are at higher risk of developing dementia than...
PET/CT, calcium blockages, heart attack risk, Intermountain study, American Heart Association, AHA Scientific Sessions 2016
News | PET-CT| November 15, 2016
Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test...
bivalirudin, heparin, blood clot prevention medication, PCI, percutaneous coronary intervention, Intermountain study, AHA Scientific Sessions
News | Antiplatelet and Anticoagulation Therapies| November 14, 2016
Two differing blood clot prevention medications are just as safe and effective for patients undergoing percutaneous...
Overlay Init